Mutations in the leptin‐melanocortin pathway and weight loss after bariatric surgery: a systematic review and meta‐analysis

Abstract

AbstractObjectiveThe objective of this meta‐analysis was to quantify the overall effects of gene mutations in the leptin‐melanocortin pathway on short‐ and long‐term weight loss after bariatric surgery.MethodsMEDLINE, PubMed, and Embase were searched, and data were analyzed using ReviewManager (RevMan) version 5.4. The datasets were divided into two subgroups based on postoperative time, and the outcome measure was the percentage of total weight loss. Meta‐regression analysis was performed, and the outcome was presented as the weighed mean difference of percentage of total weight loss.ResultsThe results showed that patients with mutations in the leptin‐melanocortin pathway experienced 3.03% lower total weight loss after bariatric surgery (mean difference, −3.03; 95% CI: −3.63 to −2.44), mainly reflected in lower long‐term postoperative weight loss (mean difference, −3.43; 95% CI: −4.09 to −2.77), whereas mutation carriers exhibited a magnitude of short‐term postoperative weight loss that was similar to patients without such mutations (total difference value, −1.13; 95% CI: −2.57 to 0.31).ConclusionsMutations in leptin‐melanocortin pathway genes reduce long‐term weight loss after bariatric surgery, whereas this effect may not be reflected during the period of rapid weight loss within 12 months. These genetic variants increase the difficulties in maintaining patients' long‐term weight loss.